INDV vs STE: fair value comparison
Indivior Pharmaceuticals, Inc. and STERIS plc · Updated 2026-09-06
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, INDV currently sits closer to the top of our discount ranking. STE carries the stronger quality grade.
| INDV | STE | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $37.37 | $224.59 |
| 12-month range | $23.46–$40.25 | $211.07–$264.24 |
| Sector rank | #30 of 113 Healthcare | #33 of 113 Healthcare |
| Quality grade | F | A |
| Momentum grade | — | A |
| Leverage | Low | Low |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: INDV fair value analysis · STE fair value analysis